Arcosa Inc is a manufacturer and producer of infrastructure-related products and solutions in the U... Show more
Arcosa, Inc. — a Dallas-based provider of infrastructure-related products and solutions — has undergone a multi-year strategic transformation that has progressively reshaped its portfolio away from cyclical, lower-margin businesses and toward aggregates and engineered structures. The company was spun off from Trinity Industries in 2018 and has since divested non-core operations, including rail components and, most recently, its inland barge manufacturing business. Following the April 2026 completion of the $450 million barge sale, Arcosa now operates exclusively through two segments: Construction Products and Engineered Structures.
The Construction Products segment is anchored by a natural and recycled aggregates platform with approximately 35 million tons of annual shipments across 109 quarries and yards in some of the fastest-growing U.S. metropolitan statistical areas (MSAs), including Texas, New Jersey, Arizona, Florida, and Tennessee. The Engineered Structures segment holds a top-three market position in utility transmission and distribution poles, traffic structures, lighting poles, and telecom structures — categories directly exposed to the generational buildout of U.S. power infrastructure.
This strategic repositioning has been validated by CRH's June 2026 announcement of an all-cash acquisition at $150 per share, representing a 25% premium to Arcosa's 60-day volume-weighted average price (VWAP) as of mid-June. CRH — the largest building materials company in North America — cited Arcosa's aggregates footprint and utility structures platform as highly complementary, reinforcing CRH's position as the "#1 infrastructure player in North America." The transaction implies an acquisition multiple of 11.5x estimated 2026 adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization), including projected run-rate cost synergies of $175 million by year three.
The forward-looking catalyst calendar for ACA is now dominated by the CRH acquisition timeline. Stockholder approval and regulatory clearances — including potential Hart-Scott-Rodino antitrust review — will be the milestones to watch, with closing anticipated in the first quarter of 2027. Any delay, unexpected regulatory condition, or competing bid could meaningfully alter the risk-reward profile.
Beyond the deal, the company's next earnings report (scheduled for early August 2026) will provide critical updates on continuing operations. In the first quarter of 2026, Arcosa delivered $571.7 million in revenue from continuing operations and raised full-year adjusted EBITDA guidance to $565 million at the midpoint — representing approximately 11% year-over-year growth. Management also guided to a record consolidated adjusted EBITDA margin of 21.3% for 2026, supported by strong pricing discipline and operating leverage in utility structures.
Another near-term catalyst involves plant conversions. Arcosa is ahead of schedule converting an idle wind tower facility in Illinois into a large utility pole plant, with production expected by the end of the second quarter of 2026. A second conversion in Oklahoma is planned, with the flexibility to run wind tower and utility pole production in parallel through 2027. These capacity investments aim to capture accelerating utility demand while rightsizing wind tower infrastructure.
On the analyst front, the CRH announcement triggered a wave of rating adjustments. Oppenheimer downgraded ACA to "Market Perform" on June 26, 2026, while Citigroup and Texas Capital each moved to "Hold" equivalents on June 23. Barclays had previously maintained an "Overweight" rating with a $140 price target in early May. The overall consensus has shifted from a predominantly "Buy" posture to roughly 5 "Hold" and 2 "Buy" ratings, with the average 12-month price target settling near $138, reflecting the acquisition-driven ceiling.
Arcosa's trajectory is inextricably linked to the macro environment governing U.S. infrastructure spending, power markets, and construction activity. Several forces stand out.
First, electricity consumption in the United States is expanding at a pace not seen in a generation, fueled by data center proliferation, reshoring of industrial activity, and broader electrification trends. This structural demand driver has direct read-through to Arcosa's utility structures backlog, where multi-year capital commitments from utility customers continue to build. Second, federal and state infrastructure budgets remain supportive. Texas — Arcosa's largest market — has a positive multi-year spending outlook, while New Jersey's Department of Transportation and Transit Authority have both approved budget increases for 2026. A multi-year surface transportation reauthorization bill is also advancing through the House Transportation and Infrastructure Committee.
On the cost side, steel tariffs represent a tangible headwind. Effective April 6, 2026, utility structures manufactured in Mexico using U.S.-sourced steel became subject to a new 10% tariff on the full value of finished products. Management has stated that contractual protections are in place to pass through the impact, but the USMCA (United States-Mexico-Canada Agreement) joint review later this year will be pivotal in determining whether these tariffs persist. Diesel costs — with Arcosa consuming roughly 10–11 million gallons annually in its Construction Products segment — have risen approximately $1.50 per gallon, creating a potential 4–5% headwind to cash unit profitability, partially mitigated through fuel surcharges and loading fees.
Residential construction, a downstream driver of aggregates demand, remains challenged by affordability pressures and weakened consumer confidence tied to elevated oil prices. Management expects flat to slightly down residential aggregates volume in 2026, with recovery potentially deferred into 2027.
For investors seeking a data-driven lens on where ACA and other tradable instruments may be headed, Tickeron's Trend Prediction Engine offers an AI-powered forecasting tool designed to assess whether a stock, ETF (exchange-traded fund), or other asset is likely to exhibit bullish, bearish, or sideways behavior over the coming week or month. The engine helps users spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of instruments — supported by searchable prediction categories, historical context, and alert-oriented functionality. Exploring predictive analytics alongside fundamental analysis can offer an additional perspective for those monitoring infrastructure-sector names like Arcosa.
Looking toward year-end 2026 and into 2027, the primary question facing ACA shareholders is whether the CRH acquisition proceeds smoothly to closing. If consummated as structured, Arcosa stockholders would receive $150 per share in cash, crystalizing the value built through years of portfolio simplification. CRH's stated intent to integrate Arcosa's aggregates and engineered structures platforms into its connected North American portfolio suggests the combined entity could unlock significant synergies in procurement, self-supply, and SG&A (selling, general, and administrative expenses).
If, for any reason, the transaction does not close, Arcosa would continue operating as a focused, two-segment infrastructure company with a strong standalone trajectory. The utility structures segment is expected to sustain momentum well beyond 2026, supported by long-duration contracts that extend into 2028. Wind towers, representing roughly 10% of total company revenue in 2026, are positioned for a volume recovery back to 2025 levels in 2027. The Construction Products segment, meanwhile, would continue benefiting from infrastructure and heavy non-residential demand, with residential aggregates recovery representing an additional potential tailwind as housing affordability improves.
Longer-term themes — the electrification of the U.S. economy, grid hardening, data center construction, LNG (liquefied natural gas) development along the Gulf Coast, and federal infrastructure reauthorization cycles — all support the underlying demand narrative. Under CRH's ownership, these secular tailwinds would be amplified by greater scale, deeper capital resources, and a broader connected portfolio. As a standalone entity, Arcosa's lean balance sheet — with pro forma net debt to adjusted EBITDA at 1.9x — and active bolt-on M&A (mergers and acquisitions) pipeline would enable continued organic and inorganic growth. Either path points to a business aligned with durable, multi-year infrastructure investment themes.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a manufacturer of infrastructure related products
Industry EngineeringConstruction
| 1 Day | |||
|---|---|---|---|
| CRYPTO / NAME | Price $ | Chg $ | Chg % |
| RAMP.X | 0.022037 | 0.004820 | +28.00% |
| RAMP cryptocurrency | |||
| CHZ.X | 0.012409 | 0.000113 | +0.92% |
| Chiliz cryptocurrency | |||
| ETH.X | 1883.991300 | 5.856323 | +0.31% |
| Ethereum cryptocurrency | |||
| IDEX.X | 0.000726 | 0.000001 | +0.19% |
| IDEX cryptocurrency | |||
| USTC.X | 0.004848 | -0.000083 | -1.68% |
| TerraClassicUSD cryptocurrency | |||
A.I.dvisor indicates that over the last year, ACA has been loosely correlated with ALG. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ACA jumps, then ALG could also see price increases.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ACA advanced for three days, in of 316 cases, the price rose further within the following month. The odds of a continued upward trend are .
The 10-day RSI Indicator for ACA moved out of overbought territory on July 20, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on August 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ACA as a result. In of 102 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ACA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.386) is normal, around the industry mean (17.179). P/E Ratio (32.357) is within average values for comparable stocks, (221.861). Projected Growth (PEG Ratio) (2.237) is also within normal values, averaging (3.120). Dividend Yield (0.001) settles around the average of (0.012) among similar stocks. P/S Ratio (2.441) is also within normal values, averaging (3.242).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.